Latest News
Keenova reports positive Phase 3 results for XIAFLEX in plantar fibromatosis
8 July 2026 - US-based therapeutics company Keenova Therapeutics plc on Wednesday reported positive Phase 3 results for XIAFLEX, its collagenase treatment for plantar fibromatosis, a chronic condition characterised by collagen-based nodules in the fo...
GE HealthCare and Mayo Clinic launch prostate cancer theranostics research study
8 July 2026 - Healthcare solutions provider GE HealthCare Technologies Inc (NASDAQ: GEHC) and non-profit organisation Mayo Clinic announced on Wednesday the launch of the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collab...
Helix partners with AstraZeneca to support genomic research for drug discovery and development
8 July 2026 - Enterprise genomics company Helix announced on Tuesday a multi-year relationship with biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).Under this agreement AstraZeneca will gain access to Helix's continuousl...
Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis
8 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Tuesday the initiation of the Phase III clinical trial for Rentosertib, its potentially first-in-class oral small-molecule inhibitor targeting TNIK for the ...
Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection
8 July 2026 - Invictus Pharmacy, a pharmacy platform managed by Invictus Ventures Inc, and Mullan Pharmaceutical Inc, a pharmaceutical company focused on expanding access to FDA-approved medications through high-capacity manufacturing partnerships an...